Data gathered: September 17
Alternative Data for Century Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 10,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 515 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Century Therapeutics
None
| Price | $0.50 |
| Target Price | Sign up |
| Volume | 40,180 |
| Market Cap | $43M |
| Year Range | $0.39 - $1.07 |
| Dividend Yield | 0% |
| Analyst Rating | 80% buy |
| Industry | Biotechnology |
In the news
 |
Nuveen LLC Invests $75,000 in Century Therapeutics, Inc. $IPSCSeptember 8 - ETF Daily News |
|
Century Therapeutics (NASDAQ:IPSC) Upgraded at Wall Street ZenSeptember 6 - ETF Daily News |
|
Deutsche Bank AG Lowers Position in Century Therapeutics, Inc. $IPSCSeptember 2 - ETF Daily News |
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment ConferenceAugust 22 - GlobeNewswire |
|
|
HC Wainwright Has Positive Estimate for IPSC Q4 EarningsAugust 21 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 0 | 0 | 0 | -33M | 0 | -0.380 |
| Q1 '25 | 109M | 0 | 109M | 77M | 77M | 0.890 |
| Q4 '24 | 4.2M | 3.3M | 4.2M | -36M | -31M | -0.410 |
| Q3 '24 | 790,000 | 3.3M | 790,000 | -31M | -28M | -0.370 |
| Q2 '24 | 770,000 | 3.5M | 770,000 | -31M | -28M | -0.380 |
Insider Transactions View All
| Russotti Gregory filed to sell 391,508 shares at $0.5. September 10 '25 |
| Pfeiffenberger Brent filed to sell 3,268,909 shares at $0.5. September 10 '25 |
| Carr Douglas filed to sell 405,423 shares at $0.5. September 10 '25 |
| Carr Douglas filed to sell 405,686 shares at $0.5. August 6 '25 |
| Russotti Gregory filed to sell 392,047 shares at $0.6. June 11 '25 |
Similar companies
Read more about Century Therapeutics (IPSC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Century Therapeutics?
The Market Cap of Century Therapeutics is $43M.
What is the current stock price of Century Therapeutics?
Currently, the price of one share of Century Therapeutics stock is $0.50.
How can I analyze the IPSC stock price chart for investment decisions?
The IPSC stock price chart above provides a comprehensive visual representation of Century Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Century Therapeutics shares. Our platform offers an up-to-date IPSC stock price chart, along with technical data analysis and alternative data insights.
Does IPSC offer dividends to its shareholders?
As of our latest update, Century Therapeutics (IPSC) does not offer dividends to its shareholders. Investors interested in Century Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Century Therapeutics?
Some of the similar stocks of Century Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.